Why Gonorrhea Is Getting Harder to Treat in Thailand and What That Means for You

You picked up antibiotics from a pharmacy near Chaweng on the way back to your hotel. Three days later, the discharge is still there. You search online, land on something about antibiotic-resistant gonorrhea in Thailand, and now you are sitting in your room wondering if a standard shot will even work. That worry is not overblown. Thailand has confirmed some of the most resistant gonorrhea strains seen anywhere in the region, and Koh Samui sits squarely in the middle of this picture.

Multidrug-resistant gonorrhea, meaning strains that resist two or more drug classes at once, has been tracked across Southeast Asia for years. Thailand consistently appears in that data. What changed in 2025 is that ceftriaxone, the last reliably effective treatment, produced confirmed resistant cases here too. This article explains what that means in practical terms, why it matters on this island specifically, and what to do if your treatment has not worked.

Why Drug-Resistant Gonorrhea in Thailand and Koh Samui Is a Real Risk

Thailand has one of the highest rates of gonorrhea antibiotic resistance in the region. Surveillance data from the Enhanced Gonococcal Antimicrobial Surveillance Programme shows ciprofloxacin resistance in Thailand now exceeds 90 percent. Azithromycin and cefixime resistance have both accelerated since 2020. These are drugs you can walk into a Thai pharmacy and buy today, without a prescription.

Koh Samui has a specific role in this picture. High tourist turnover, short stays, and a habit of buying antibiotics at island pharmacies before seeing a doctor all push resistance forward. Two foreign patients diagnosed with ceftriaxone-resistant gonorrhea in Thailand in 2025 were lost to follow-up before treatment was confirmed as successful. That is not an abstract risk. It happens here.

The Pharmacy Problem and Why It Makes Things Worse

Someone notices symptoms, feels uncomfortable going to a clinic, walks into a pharmacy on the ring road, and walks out with ciprofloxacin or azithromycin. Sometimes symptoms ease briefly. Sometimes nothing changes. Either way, the wrong antibiotic at the wrong dose does not clear the infection. It selects for bacteria that can survive that drug, and those bacteria get passed on.

Over-the-counter antibiotic use does the opposite of what good treatment should do. In Thailand, where OTC antibiotics are easier to get than in most other countries, this cycle runs fast. If you bought antibiotics from a pharmacy and still have symptoms, those antibiotics were almost certainly the wrong choice, and the infection may now be harder to treat.

The Infection Sites Clinics Often Miss

Most people think of gonorrhea as a genital infection. But it can infect the throat and rectum too, and at these sites it is often completely silent. A standard urine PCR test will not detect throat or rectal gonorrhea. You need separate swabs from each site.

This matters because these sites are reservoirs. Throat gonorrhea is harder to clear even with ceftriaxone, and it can spread through sexual contact while remaining entirely undetected. At Doctor Samui’s Chaweng clinic, we ask specifically about sexual history to determine which sites need testing. A urine test alone is not enough for everyone.

What Happens When First-Line Treatment Fails

The signs of treatment failure are straightforward. Symptoms that persist or return within two weeks of receiving a full, correctly dosed ceftriaxone injection at a clinic. Not symptoms that ease and disappear. Symptoms that stay or come back.

Genuine treatment failure with correctly dosed injected ceftriaxone is still uncommon. But the genetic change in the gonorrhea bacteria that drives ceftriaxone resistance has now been confirmed in Thailand. Extensively drug-resistant gonorrhea means a strain that resists nearly every currently available antibiotic. Most patients are not there yet, but the direction of travel is clear, and it changes what good clinical care looks like right now.

If your symptoms have not cleared after treatment, the answer is not more pharmacy antibiotics. You need a proper repeat PCR test, a culture and sensitivity assessment, and a clinical review of exactly what treatment you received, when, and at what dose.

What a Resistance-Aware Gonorrhea Clinic on Koh Samui Should Actually Offer

There is a difference between a clinic that gives you a standard ceftriaxone injection and one that assesses why you might need a different approach. The single-dose ceftriaxone injection is still the correct first-line treatment in most cases. But the dose matters. The site of infection matters. Your treatment history matters.

A proper gonorrhea assessment includes a full sexual history, site-appropriate sampling, PCR testing, and for patients with a prior treatment failure, a discussion of culture and sensitivity testing and dose adjustment. A test of cure, meaning a repeat test one to two weeks after treatment, is now clinically advisable for all gonorrhea cases treated in Thailand. If you cannot return to the clinic in person, that follow-up can happen via a hotel visit. You can review our sexual health services page for the full list of what we offer, including same-day testing and treatment options.

What Happens If You Leave Koh Samui Before Treatment Is Confirmed

This is the gap that recent Thai surveillance data made explicit. Tourists get diagnosed, receive treatment, and leave before anyone knows if the infection cleared. Back home, they either assume they are fine or struggle to find a doctor who has the treatment context they need.

If you are leaving Koh Samui in the next day or two and have just been diagnosed or treated, ask for a written treatment summary before you go. Ask for the drug name, dose, route of administration, and date. This gives your doctor at home what they need to order a test of cure and manage follow-up correctly. Do not assume one injection closes the case. With the strains currently circulating in Thailand, continuity of care after you leave the island matters.

New Treatments Being Studied and What to Know Right Now

Zoliflodacin is a new antibiotic being evaluated specifically for drug-resistant gonorrhea. The Global Antibiotic Research and Development Partnership has included Thailand in its trial sites, which reflects how seriously the resistance problem here is taken internationally. Zoliflodacin is not yet standard treatment and is not something you can access at a clinic today.

What this means for you right now is that ceftriaxone by injection, at the correct dose, from a qualified clinician, with a test of cure to follow, is still the benchmark. The pipeline gives real reason for optimism, but it does not change what the right treatment looks like in 2025 and 2026.